ICYMI 2021 Rheumatology Year In Review Save
Dr. Jack Cush recants the top stories and changes for the field of rheumatology in 2021.
My Top 10 list
1. New FDA Approvals: voclosporin, anifrolumab, avacopan, efgartigimod
2. New FDA Indications
3. New Biologics for Lupus
4. Super "H" Hydroxychloroquine
5. Zoomatology
6. Avacopan
7. Tocilizumab
8. FDA & JAK inhibitor warnings
9. New Biologics for GCA
10. IL-23 Inhibitors
https://rheumnow.com/news/2021-rheumatology-year-review-172022
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.